explore -WSS

explore

author：leisure time 2025-10-04 07:15:38 - browse：2875

The biotech company Acelyrin, which raised more than $500 million in an IPO this year, ran into its first major setback Monday as its investigational anti-inflammatory drug missed the primary goal in a pivotal clinical trial.

Acelyrin’s medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with the common skin disease hidradenitis suppurativa, or HS, an inflammatory disorder that leads to abscesses and scars. But after 16 weeks of treatment, patients who received izokibep did not show significant improvements compared to those taking a placebo, failing the study’s primary endpoint.

Acelyrin’s share price fell more than 60% in after-hours trading Monday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： AI gets buy

Wikipedia

WSS

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Hey, doctors: Don't be no

Prosecutors say FTX founder Sam Bankman

A former Republican legislative candidate has been charged for his role in the US Capitol riot

AI gets buy

Unique patient identifier: Experts argue the benefits, pitfalls

Wikipedia

explore

hotspot

Drug repurposing or repositioning? The language matters

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Dobbs anniversary: the lost opportunity of abortion as health care

Adopting new red light myopia treatments may be short

As demand for Covid shots wanes, Moderna seeks its next success

'The View' co

23andMe had bad news about my health. I wish a person had delivered it

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Drug repurposing or repositioning? The language matters

Pfizer's RSV vaccine recommended for approval in Europe

focus

How Brent Saunders' Allergan experiment failed

Bernie brings in new pharma CEOs to talk drug prices

'The View' co

A new deal aims to ramp up use of AI in rehab care decisions

Hey, doctors: Don't be no

Global cancer cases to surge 77% by 2050, WHO report says

hotspot

Wikipedia

hotspot

Wikipedia